e.g. mhealth
Search Results (1 to 10 of 44 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 7 JMIR Formative Research
- 7 JMIR Medical Informatics
- 7 JMIRx Med
- 5 Journal of Medical Internet Research
- 4 JMIR Research Protocols
- 3 JMIR Dermatology
- 3 JMIR Human Factors
- 2 JMIR Public Health and Surveillance
- 2 JMIR mHealth and uHealth
- 1 JMIR AI
- 1 JMIR Cancer
- 1 JMIR Medical Education
- 1 JMIR Serious Games
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section

Pharmaceutical manufacturers play a crucial role in meeting health care professionals’ information needs by providing them with scientific response documents (SRDs). These documents provide comprehensive and evidence-based answers to unsolicited questions concerning a medication or disease state [1]. The development and maintenance of SRDs are entrusted to the medical information department within these organizations.
JMIR AI 2025;4:e55277
Download Citation: END BibTex RIS

Telemedicine Prescribing by US Mental Health Care Providers: National Cross-Sectional Survey
pharmaceutical
JMIR Form Res 2025;9:e63251
Download Citation: END BibTex RIS

In 2022, entrepreneur Mark Cuban launched the Mark Cuban Cost Plus Drug Company (Cost Plus)—a public benefit corporation with a vertically integrated supply chain—to address rising pharmaceutical costs [2,5]. Cost Plus offers medications for a 15% markup and a US $5 pharmacy fee, allowing for significant cost savings [5]. Studies have found that pharmacy coupon websites can lead to significant savings for patients within dermatology, with Good Rx providing some of the highest rates of saving [6].
JMIR Dermatol 2024;7:e64300
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section